Compier Agreements (SDEA)

Home / Innovation / Compier Agreements (SDEA)

Leverage the Power of Digital Safety Data Exchange Agreements and Streamline Partner Oversight

Pharmaceutical company outsource the various processes of Pharmacovigilance to a service provider to carry out the business process. For every active partner, the PVA Agreement also called as Safety Data Exchange Agreement becomes a mandate. The various phases of establishing the executive agreement is an extended process involving multiple stakeholders resulting in the scattered information passed through various channels.

In recent years with the increasing number of programs has increased the number of active PVA agreements. The PVA office and PV QA team are in turmoil with source truth and maintenance of the PV Agreements. The PV team do not have oversight over the partner performance on various aspects.

How Compier SDEA can Help

Compier Agreements (SDEA) facilitates management of PV Agreements with functions of Authoring, Review, Approval, Tracking and Compliance Adherence. The module can ensure compliance to having an active agreement in place for any programs being managed by a pharma company which requires a PV Agreement.

AccelStudy Image

Solution Capabilities

  • Partner Data Management
  • Digital Agreement Authoring
  • Modular and Templatized Authoring
  • SLA Definition and Management
  • Collaborative Agreement Review
  • Electronic Signatures for Approvals
  • Agreement Version Control
  • Alerts and Notification Engine
  • Integration with Exchange and Reconciliation
  • Auto ePSMF Updates
  • Agreements Oversight Dashboards

Business Advantages

  • Global Compliance Adherence on PV Agreements
  • Achieve Complete Partner Compliance Oversight
  • Optimize Operational Efficiency on Agreements Management
  • Audit Readiness with PSMF Updates and Reports

How Do we Deliver

Compier Agreements (SDEA) module is a component of our Compier platform. It can be deployed on its own or in combination with other modules of the platform. Our technology platform and subject matter expertise enable you with a comprehensive solution to digitalize the PV Agreement  (SDEA) and track the Vendor performance on Timelines and Quality ensuring process and performance optimization

New Insights

4 Effective Strategies to Accelerate Site Selection to Activation

Introduction to the site selection process Clinical research organizations (CRO) predominantly rely on the internal networks and investigator database to support a clinical study for a drug. As the clinical sphere continues to expand at a rapid pace, there is an upsurge in demand for clinical trial sites worldwide. CROs are striving for new sites […]

Aggregate Reporting – Significance, Classification and Challenges

Aggregate reports are the cumulative reports in the database that emphasise on evaluation of safety profile and risk-benefit analysis of a drug. Aggregate reporting is the process of compilation and submission of aggregate reports to the regulatory agencies over the period of the product’s life cycle (during pre-marketing and post-marketing phase) to provide a comprehensive [...]

Literature Screening – Process overview, challenges en-route and the scope for automation

Medical and scientific literature is a valuable source of safety information that helps in monitoring benefit-risk profiles and emerging safety issues of medicinal products. Literature screening is conducted to ascertain abstracts and articles that provide crucial information on serious and non-serious Individual Case Safety Reports (ICSR) reports and risk-benefit assessment of a drug. The scientific […]

Get in Touch with Us